BWX Technologies Q2 revenue up 12%, beats estimates
Overview
BWX Technologies Q2 revenue rises 12% yr/yr, beating analyst expectations
Adjusted EBITDA for Q2 increases 16%, exceeding analyst estimates, per LSEG data
Co raises 2025 adjusted EBITDA and non-GAAP EPS guidance, citing strong results
Outlook
BWX Technologies raises 2025 revenue guidance to ~$3.1 bln
Company increases 2025 adjusted EBITDA guidance to $565 mln-$575 mln
BWX Technologies expects 2025 non-GAAP EPS of $3.65-$3.75
Company raises 2025 free cash flow guidance to $275 mln-$285 mln
Result Drivers
GOVERNMENT OPERATIONS - Revenue increase driven by higher naval nuclear component production and special materials processing
COMMERCIAL OPERATIONS - Revenue growth attributed to acquisitions and higher medical sales
FIELD SERVICES - Lower activity due to timing of life-extension and outage projects
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $764 mln | $710.80 mln (10 Analysts) |
Q2 EPS | $0.85 | ||
Q2 Net Income | $78.50 mln | ||
Q2 Adjusted EBITDA | Beat | $145.90 mln | $125.40 mln (10 Analysts) |
Q2 Free Cash Flow | $126.30 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the aerospace & defense peer group is "buy"
Wall Street's median 12-month price target for BWX Technologies Inc is $150.00, about 0.3% above its August 1 closing price of $149.50
The stock recently traded at 40 times the next 12-month earnings vs. a P/E of 30 three months ago
Press Release:
